Topic

Blue Cross Blue Shield (BCBS Association)

A collection of 1095 issues

Myths vs. Facts: Getting Onpattro (patisiran) Covered by Blue Cross Blue Shield in California

Answer Box: Onpattro Coverage with Blue Shield California Getting Onpattro (patisiran) covered by Blue Shield of California requires prior authorization with genetic TTR mutation proof, neurologist evaluation, and ICD-10 code E85.1 documentation. Submit via AuthAccel portal with clinical records showing hATTR polyneuropathy and functional status. If denied, file internal

How to Get Hetlioz LQ (Tasimelteon) Covered by Blue Cross Blue Shield in Illinois: Complete Guide with Forms and Appeal Scripts

Answer Box: Getting Hetlioz LQ Covered by Blue Cross Blue Shield in Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Hetlioz LQ (tasimelteon oral suspension) for Smith-Magenis syndrome in children ages 3-15. The fastest path to approval: (1) Confirm your child's SMS diagnosis with genetic

How to Get Xospata (Gilteritinib) Covered by Blue Cross Blue Shield in Illinois: Complete PA Guide & Appeal Process

Answer Box: Getting Xospata Covered by BCBS Illinois Blue Cross Blue Shield of Illinois requires prior authorization for Xospata (gilteritinib), typically placing it in non-preferred specialty tiers with quantity limits. Success requires documented FLT3-mutated relapsed/refractory AML, prior therapy failures, and prescriber attestation. Your first step: Have your hematologist/oncologist

How to Get Takhzyro (lanadelumab-flyo) Covered by Blue Cross Blue Shield California: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Takhzyro Covered by Blue Cross Blue Shield California Blue Cross Blue Shield California requires prior authorization for Takhzyro (lanadelumab-flyo) for hereditary angioedema (HAE). To get approved: (1) Your doctor submits a PA request with HAE diagnosis confirmation (low C4/C1-INH labs), attack frequency logs, and failed step

The Complete Requirements Checklist to Get Sylvant (siltuximab) Covered by Blue Cross Blue Shield in Virginia

Answer Box: Getting Sylvant Covered by Blue Cross Blue Shield in Virginia Fastest Path to Approval: Anthem Blue Cross Blue Shield Virginia requires prior authorization for Sylvant (siltuximab) under clinical criteria CC-0113. You must prove HIV-negative and HHV-8-negative multicentric Castleman disease with supporting pathology and lab results. Submit through Anthem&

How to Get Orladeyo (berotralstat) Covered by Blue Cross Blue Shield in Washington: Prior Authorization, Appeals, and Cost Assistance Guide

Answer Box: Getting Orladeyo Covered by Blue Cross Blue Shield in Washington Orladeyo (berotralstat) requires prior authorization from Blue Cross Blue Shield plans in Washington, with coverage typically requiring confirmed HAE diagnosis, age ≥12 years, and prophylaxis indication. Your fastest path to approval: 1. Gather documentation: HAE diagnosis with C1-INH/

Getting Adynovate (Antihemophilic Factor VIII) Covered by Blue Cross Blue Shield in New Jersey: Complete Prior Authorization and Appeals Guide

Answer Box: Fast Track to Adynovate Coverage Adynovate (antihemophilic factor VIII, pegylated) requires prior authorization from Blue Cross Blue Shield in New Jersey. Submit PA through your plan's Medical Injectables Program with hemophilia A diagnosis, factor levels, bleeding history, and prophylaxis rationale. If denied, you have 180 days

Renewing Sumavel DosePro (Sumatriptan Injection, Needle-Free) Approval with Blue Cross Blue Shield in North Carolina: Annual Requirements & Timeline

Answer Box: Renewing Your Sumavel DosePro Authorization Blue Cross Blue Shield of North Carolina typically requires annual prior authorization renewal for Sumavel DosePro (sumatriptan injection, needle-free). Start the renewal process 60-90 days before your current approval expires to avoid coverage gaps. You'll need updated clinical documentation showing continued

How to Get Humate-P Covered by Blue Cross Blue Shield in Washington: Complete Guide to Prior Authorization, Appeals, and Home Infusion

Answer Box: Humate-P (antihemophilic factor/vWF complex) requires prior authorization from Blue Cross Blue Shield plans in Washington, including Premera and Regence. First step: Have your hematologist submit a PA request with VWD subtype documentation, DDAVP trial results, and weight-based dosing calculations through your plan's provider portal. Standard

The Requirements Checklist to Get Strimvelis (Autologous CD34+ ADA-SCID Gene Therapy) Covered by Blue Cross Blue Shield in Pennsylvania

Answer Box: Fast Track to Approval Getting Strimvelis (autologous CD34+ ADA-SCID gene therapy) covered by Blue Cross Blue Shield in Pennsylvania requires prior authorization via medical exception due to non-FDA approval and international treatment location (SR-TIGET, Milan). Success depends on: (1) confirmed ADA-SCID diagnosis with biallelic ADA mutations and enzyme